Pfizer gets $22.5bn debt financing
Pfizer, the US drugs group, has secured $22.5bn of debt to back its bid for local rival Wyeth, a result that will provide some encouragement to syndicated loan markets globally.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ European securitization issuance database
- ✔ Daily newsletters across markets and asset classes
- ✔ 1 weekly securitization podcast
